Negatol (Policresulen) is a topical hemostatic and antiseptic indicated for common anal disorders, such as hemorrhoids, and for gynecological infections. Policresulen has hemostatic activity by causing coagulation of blood proteins and promoting the contraction of the muscular fibers of the blood vessels of small caliber. Policresulen promotes selective chemical debridement: being an anion, it has the ability to interact only with the phospholipid molecules of the plasma membranes of to devitalized cells, which have lost its original electric charge. This contact provides the denaturation of cellular proteins, facilitating their removal. Its acidity, together with coagulating properties, give policresulen antimicrobial activity against staphylococcus spp., streptococcus spp. and Candida albicans. Policresulen is often used for gynecological infections. It is also used to treat canker sore in some countries.
Approval Year
Substance Class |
Polymer
Created
by
admin
on
Edited
Sat Dec 16 09:51:29 GMT 2023
by
admin
on
Sat Dec 16 09:51:29 GMT 2023
|
Record UNII |
6I19M5GB0G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QG01AX03
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
||
|
WHO-VATC |
QD08AE02
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
||
|
WHO-ATC |
D08AE02
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
||
|
WHO-VATC |
QG51AD02
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
||
|
WHO-ATC |
G01AX03
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6I19M5GB0G
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
m8943
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID70143913
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
4691
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
101418-00-2
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106937
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
100000092511
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
6I19M5GB0G
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
DB13492
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
5952
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
POLICRESULEN
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
SUB09966MIG
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | |||
|
54908
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY | RxNorm | ||
|
C166940
Created by
admin on Sat Dec 16 09:51:29 GMT 2023 , Edited by admin on Sat Dec 16 09:51:29 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUB_CONCEPT->SUBSTANCE |